BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 18482192)

  • 1. Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry.
    Larsen R; Berkowicz A; Lousen T; Hedegaard M; Clausen FB; Krog GR; Dziegiel MH
    Transfusion; 2008 Aug; 48(8):1707-12. PubMed ID: 18482192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massive antenatal fetomaternal hemorrhage: evidence for long-term survival of fetal red blood cells.
    Dziegiel MH; Koldkjaer O; Berkowicz A
    Transfusion; 2005 Apr; 45(4):539-44. PubMed ID: 15819674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of feto-maternal hemorrhage in an artificial model using anti-D and anti-fetal hemoglobin antibody by flow cytometry.
    Pourazar A; Homayouni V; Rezaei A; Andalib A; Oreizi F
    Iran Biomed J; 2008 Jan; 12(1):43-8. PubMed ID: 18392094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of fetomaternal hemorrhage.
    Kim YA; Makar RS
    Am J Hematol; 2012 Apr; 87(4):417-23. PubMed ID: 22231030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of fetomaternal haemorrhage and F cells in unusual maternal blood samples by flow cytometry using anti-D and anti-HbF.
    Kumpel BM; MacDonald AP; Bishop DR; Yates AF; Lee E
    Transfus Med; 2013 Jun; 23(3):175-86. PubMed ID: 23578132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetomaternal hemorrhage in normal vaginal delivery and in delivery by cesarean section.
    Lubusky M; Simetka O; Studnickova M; Prochazka M; Ordeltova M; Vomackova K
    Transfusion; 2012 Sep; 52(9):1977-82. PubMed ID: 22313121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined flow cytometry-based method for fetomaternal hemorrhage and maternal D.
    Radel DJ; Penz CS; Dietz AB; Gastineau DA
    Transfusion; 2008 Sep; 48(9):1886-91. PubMed ID: 18513253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection.
    Chen JC; Davis BH; Wood B; Warzynski MJ
    Cytometry; 2002 Dec; 50(6):285-90. PubMed ID: 12497589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive anti-D after massive fetomaternal hemorrhage].
    Strobel E; Hofmeister G; Wüllenweber J
    Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):223-8. PubMed ID: 7789712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of haemoglobin F detection by the acid elution test, flow cytometry and high-performance liquid chromatography in maternal blood samples analysed for fetomaternal haemorrhage.
    Chambers E; Davies L; Evans S; Birchall J; Kumpel B
    Transfus Med; 2012 Jun; 22(3):199-204. PubMed ID: 22429383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting fetomaternal hemorrhage by flow cytometry.
    Dziegiel MH; Nielsen LK; Berkowicz A
    Curr Opin Hematol; 2006 Nov; 13(6):490-5. PubMed ID: 17053464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fetomaternal transfusion in relation to mode of delivery. Comparison of data from the DFG multicenter study "Rhesus negative" (1965-70) with data from the Freiburg University Gynecologic Clinic (1989)].
    du Bois A; Quaas L; Lorbeer H; Rasenack R; Geyer H
    Zentralbl Gynakol; 1991; 113(17):927-33. PubMed ID: 1720912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis.
    Kumpel B; Hazell M; Guest A; Dixey J; Mushens R; Bishop D; Wreford-Bush T; Lee E
    Transfusion; 2014 May; 54(5):1305-16. PubMed ID: 24236535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged anemia in an intrauterine-transfused neonate with Rh-hemolytic disease: no evidence for anti-D-related suppression of erythropoiesis in vitro.
    Dorn I; Schlenke P; Härtel C
    Transfusion; 2010 May; 50(5):1064-70. PubMed ID: 20003047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of F cells in β-thalassemia.
    Prus E; Fibach E
    Transfusion; 2013 Mar; 53(3):499-504. PubMed ID: 22738617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of asymptomatic massive fetomaternal hemorrhage.
    Peedin AR; Mazepa MA; Park YA; Weimer ET; Schmitz JL; Raval JS
    Transfus Apher Sci; 2015 Apr; 52(2):208-10. PubMed ID: 25736586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two techniques for the evaluation of fetomaternal hemorrhage in RhD-negative women: gel agglutination and haemoglobin F determination by flow cytometry.
    Ben-Haroush A; Belkin A; Chezar J; Orlin J; Hod M; Bar J
    Acta Obstet Gynecol Scand; 2007; 86(7):821-6. PubMed ID: 17611827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method: evaluation of the Fetal Cell Count kit.
    Porra V; Bernaud J; Gueret P; Bricca P; Rigal D; Follea G; Blanchard D
    Transfusion; 2007 Jul; 47(7):1281-9. PubMed ID: 17581165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.